Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 249 Breast Neoplasms 136 Neoplasms 108 Prostatic Neoplasms 35 Fatigue 35 Obesity 25 Lung Neoplasms 24 Colorectal Neoplasms 24 Polycystic Ovary Syndrome 17 Colonic Neoplasms 16 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Pancreatic Neoplasms 11 Lymphoma 11 Lymphedema 11 Hematologic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Rectal Neoplasms 10 Multiple Myeloma 10 Head and Neck Neoplasms 10 Leukemia 9 Cardiotoxicity 9 Insulin Resistance 8 Brain Neoplasms 8 Stomach Neoplasms 7 Peripheral Nervous System Diseases 7 Overweight 6 Esophageal Neoplasms 6 Cognitive Dysfunction 6

Interventions

Bevacizumab 4 Temozolomide 3 Irinotecan 3 Sorafenib 2 Radiosurgery 2 pembrolizumab 1 ibrutinib 1 Vorinostat 1 Valproic Acid 1 Transcranial Magnetic Stimulation 1 Therapeutics 1 Thalidomide 1 Surveys and Questionnaires 1 Standard of Care 1 Sildenafil Citrate 1 Radiotherapy 1 Pliability 1 Plasma Exchange 1 Palliative Care 1 Nivolumab 1 Morphine 1 Methadone 1 Lenalidomide 1 Laparoscopy 1 Immunoglobulins 1 Exercise 1 Equipment and Supplies 1 Eating 1 Cytidine Triphosphate 1 Clomipramine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neurologic Manifestations × Exercise × Clear all

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡